Celldex Therapeutics Inc. (CLDX)
NASDAQ: CLDX
· Real-Time Price · USD
25.48
0.54 (2.17%)
At close: Aug 15, 2025, 3:59 PM
25.50
0.08%
After-hours: Aug 15, 2025, 04:54 PM EDT
Celldex Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -199.61M | -178.85M | -157.86M | -154.08M | -150.22M | -144.88M | -141.43M | -124.61M | -113.13M | -118.64M | -112.33M | -105.99M | -99.65M | -77.02M | -70.51M | -72.26M | -66.03M | -63.69M |
Depreciation & Amortization | -9.04M | -9.12M | -9.21M | -9.27M | 3.1M | 3.06M | 3.01M | 2.92M | 2.83M | 2.81M | 2.9M | 3M | 3.08M | 3.1M | 3.07M | 3.05M | 3.15M | 3.54M |
Stock-Based Compensation | 37.91M | 36.36M | 34.24M | 31.67M | 29.18M | 26.75M | 23.89M | 21.19M | 18.56M | 16.8M | 15.61M | 14.24M | 12.78M | 10.83M | 8.95M | 7.07M | 5.29M | 4.5M |
Other Working Capital | -25.71M | -26.9M | -35.16M | -30.91M | 432K | -2.72M | 9.38M | 3.72M | -16.01M | 444K | -6.85M | -4.83M | 9.65M | -6.44M | -6.28M | -4.5M | -4.83M | -3.3M |
Other Non-Cash Items | 749K | -2.31M | -3.35M | -42.05M | -11.85M | -8.27M | -6.22M | 35.32M | -1.35M | -5.93M | -4.43M | -4.19M | -7.41M | -1.42M | -1.17M | 13.29M | 15.59M | 10.2M |
Deferred Income Tax | n/a | n/a | n/a | 39.89M | n/a | n/a | n/a | -39.89M | n/a | n/a | n/a | 227K | n/a | -125K | -197K | -1.36M | -1.23M | 1.87M |
Change in Working Capital | -16.2M | -17.59M | -21.6M | -24M | 8.3M | 3.98M | 13.46M | 8.55M | -18.04M | -1.23M | -3.9M | -2.21M | 13.53M | -2.73M | -1.05M | -1.38M | -3.85M | -2.8M |
Operating Cash Flow | -186.19M | -171.51M | -157.78M | -157.84M | -121.49M | -119.36M | -107.29M | -96.52M | -112.72M | -107.77M | -103.73M | -96.49M | -77.67M | -67.36M | -60.91M | -51.6M | -47.09M | -46.38M |
Capital Expenditures | -1.13M | -677K | -756K | -666K | -1.44M | -1.58M | -1.82M | -1.39M | -1.57M | -1.84M | -1.83M | -1.95M | -1.79M | -1.26M | -1.25M | -1.14M | -1.12M | -1.88M |
Cash Acquisitions | n/a | n/a | n/a | -585K | -12.39M | -13.96M | -13.38M | -12.72M | -920K | -25.3M | -25.31M | -25.38M | -25.38M | 578K | 27K | 25K | 24K | 24K |
Purchase of Investments | -503.32M | -549.57M | -789.92M | -902.13M | -829.83M | -742.89M | -424.56M | -239.52M | -274.54M | -245.92M | -188.97M | -197.15M | -373.99M | -372.8M | -389.88M | -362.27M | -173.62M | -254.29M |
Sales Maturities Of Investments | 670.22M | 619.44M | 501.71M | 418.63M | 309.82M | 270.91M | 320.6M | 337.5M | 384.06M | 379.82M | 280.67M | 238.81M | 165.7M | 124.79M | 174.95M | 197M | 192.6M | 179.4M |
Other Investing Acitivies | -1.16M | -1.16M | -1.16M | -578K | 12.39M | 13.96M | 13.38M | 12.72M | 24.33M | 48.71M | 48.72M | 48.79M | 25.38M | -14.34M | -13.74M | -13.72M | -13.71M | 79K |
Investing Cash Flow | 164.6M | 68.03M | -290.13M | -485.34M | -521.45M | -473.56M | -105.78M | 96.59M | 108.01M | 132.13M | 89.94M | 39.78M | -210.07M | -249.26M | -216.16M | -166.36M | 17.92M | -76.7M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -25K | -25K | -25K | -25K | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 432.68M | 432.68M | 436.5M | 3.81M | 3.81M | 3.95M | 827K | 2.22M | 4.53M | 4.47M | 4.08M | 3.11M | 2.81M | 2.71M | 2.48M | 2.1M | 287K | 312K |
Financial Cash Flow | 1.89M | 5.54M | 441.45M | 658.44M | 657.46M | 653.88M | 218.46M | 2.48M | 4.53M | 4.47M | 4.08M | 3.11M | 272.7M | 272.6M | 272.37M | 271.99M | 4.58M | 169.66M |
Net Cash Flow | -19.7M | -97.94M | -6.46M | 15.27M | 14.52M | 60.95M | 5.38M | 2.55M | -177K | 28.83M | -9.71M | -53.6M | -15.04M | -44.02M | -4.69M | 54.03M | -24.58M | 46.59M |
Free Cash Flow | -187.06M | -171.92M | -158.53M | -158.5M | -122.93M | -120.94M | -109.11M | -97.91M | -114.29M | -109.61M | -105.56M | -98.44M | -79.46M | -68.62M | -62.16M | -52.74M | -48.2M | -48.26M |